NCT02201056View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-935

TAK-935 oral solution

DRUG

Placebo

TAK-935 placebo-matching oral solution

Trial Locations (1)

Unknown

Lincoln

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY